| Members |
targetComponentId |
| ([D]Glucose blood level abnorm) or (hyperglycaemia &/or [drug induced]) (situation) |
Hyperglycemia |
| ([D]Glucose blood level abnorm) or (hyperglycaemia &/or [drug induced]) (situation) |
Drug-induced hyperglycemia (disorder) |
| ([D]Hypersomnia with sleep apnoea) or (sleep apnoea syndrome) (situation) |
Sleep apnea |
| ([D]Hypersomnia with sleep apnoea) or (sleep apnoea syndrome) (situation) |
Hypersomnia with sleep apnea |
| ([D]Hypersomnia with sleep apnoea) or (sleep apnoea syndrome) (situation) |
Breathing-related sleep disorder |
| ([HIV] or [AIDS] risk lifestyle) or (multiple sexual partners) |
Human immunodeficiency virus risk lifestyle (finding) |
| ([HIV] or [AIDS] risk lifestyle) or (multiple sexual partners) |
Multiple sexual contacts |
| ([Lloyd's] or [Schmidt's] syndrome) or (other combinations of endocrine dysfunction) (disorder) |
pathologie endocrinologique |
| ([Lloyd's] or [Schmidt's] syndrome) or (other combinations of endocrine dysfunction) (disorder) |
polyendocrinopathie auto-immune |
| ([Lloyd's] or [Schmidt's] syndrome) or (other combinations of endocrine dysfunction) (disorder) |
Polyglandular autoimmune syndrome, type 2 |
| ([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
présence du patient demandée |
| ([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
consultation de suivi |
| ([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
Provider-initiated encounter |
| ([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) (procedure) |
Provider-initiated encounter |
| ([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) (procedure) |
présence du patient demandée |
| ([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) (procedure) |
consultation de suivi |
| ([Thyrotoxicosis] or [hyperthyroidism]) or (toxic goitre) (disorder) |
Toxic goiter |
| ([Tiredness] or [fatigue] or [lethargy] or [malaise] symptom) or (C/O "muzzy head") |
Tired |
| ([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
Vitreous opacities (disorder) |
| ([Vitreous floaters] &/or [opacities]) or (vitreous detachment) (disorder) |
corps flottants du vitré |
| ([Vitreous floaters] &/or [opacities]) or (vitreous detachment) (disorder) |
décollement du corps vitré |
| ([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
corps flottants du vitré |
| ([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
décollement du corps vitré |
| .21 inch caliber bullet |
Bullet |
| .22 inch caliber bullet |
Bullet |
| .25 inch caliber bullet |
Bullet |
| .270 inch caliber bullet |
Bullet |
| .28 inch caliber bullet |
Bullet |
| .30 inch caliber bullet |
Bullet |
| .303 inch caliber bullet |
Bullet |
| .32 inch caliber bullet |
Bullet |
| .338 inch caliber bullet |
Bullet |
| .35 inch caliber bullet |
Bullet |
| .375 inch caliber bullet |
Bullet |
| .38 inch caliber bullet |
Bullet |
| .40 inch caliber bullet |
Bullet |
| .41 inch caliber bullet |
Bullet |
| .44 inch caliber bullet |
Bullet |
| .45 inch caliber bullet |
Bullet |
| .50 inch caliber bullet |
Bullet |
| .55 inch caliber bullet |
Bullet |
| .60 inch caliber bullet |
Bullet |
| 0 Buck shot |
Shotgun shot |
| 0 Buck shot |
grosseur du plomb |
| 00 Buck shot |
grosseur du plomb |
| 00 Buck shot |
Shotgun shot |
| 1 Buck shot |
Shotgun shot |
| 1 Buck shot |
grosseur du plomb |
| 1-Naphthalene measurement |
Naphthalene measurement |
| 10 mm caliber bullet |
Bullet |
| 10-30% body burnt |
Burn any degree involving 10-19 percent of body surface |
| 10-30% body burnt |
Burn any degree involving 20-29 percent of body surface |
| 10-30% body burnt |
Burn any degree involving 30-39 percent of body surface |
| 10-30% body burnt |
Burn any degree involving 20-29 percent of body surface |
| 10-30% body burnt |
Burn any degree involving 10-19 percent of body surface |
| 10-30% body burnt |
Burn any degree involving 30-39 percent of body surface |
| 11-hydroxyetiocholanolone |
11-hydroxyandrosterone (substance) |
| 15 year examination |
Child 15 year examination (procedure) |
| 15 year examination |
Child 15 year examination (procedure) |
| 15 year examination (procedure) |
Child 15 year examination (procedure) |
| 16-dehydroprogesterone hydratase |
16-alpha-hydroxyprogesterone dehydratase |
| 17-Beta-estriol |
Estradiol |
| 18-Hydroxydeoxycortisol measurement |
18-Hydroxycortisol measurement |
| 1q partial trisomy syndrome (disorder) |
Trisomy 1q syndrome (disorder) |
| 1q partial trisomy syndrome (disorder) |
Partial trisomy of long arm of chromosome 1 (disorder) |
| 2,2-Dichloro-1,1-difluoroethylmethyl ether |
Methoxyflurane |
| 2-Thio,4-Carboxythiazolidine |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid |
| 2-Thio,4-carboxythiazolidine measurement |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid measurement (procedure) |
| 21q partial trisomy syndrome (disorder) |
21q partial distal trisomy (disorder) |
| 21q partial trisomy syndrome (disorder) |
21q partial trisomy (disorder) |
| 22q11 microdeletion with complete DiGeorge sequence (disorder) |
22q11.2 deletion syndrome (disorder) |
| 24 hour urine volume (& level) |
24 hour urine volume - finding |
| 24 hour urine volume (& level) |
24 hour urine sample volume measurement |
| 3 Buck shot |
Shotgun shot |
| 3 Buck shot |
grosseur du plomb |
| 3 day fecal fat estimation (& level) |
3 day faecal fat estimation |
| 3,4 Methylhippurate |
Para-methyl hippurate (substance) |
| 3,4-Methylhippurate measurement |
para-Methyl hippurate measurement (procedure) |
| 3-Hydroxybutylcarnitine |
3-hydroxybutyrylcarnitine (substance) |
| 3-Hydroxybutylcarnitine measurement |
3-hydroxybutyrylcarnitine measurement |
| 3-tree-Pharmacia pollen mix |
Tree pollen (substance) |
| 3-tree-Pharmacia pollen mix allergen (substance) |
Tree pollen (substance) |
| 3/4 crown |
Crown |
| 30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
| 4 Buck shot |
Shotgun shot |
| 4 Buck shot |
grosseur du plomb |
| 4,5-Dihydroxyhexanolactone |
4,5-dihydroxyhexanoate (substance) |
| 4-Allylmethoxy-2-phenol |
Eugenol |
| 4-Hydroxyphenylpyruvate dioxygenase deficiency |
Hawkinsinuria (disorder) |
| 4-Hydroxyphenylpyruvate dioxygenase deficiency |
4-Hydroxyphenylpyruvate dioxygenase deficiency (disorder) |
| 4-Hydroxyphenylpyruvate dioxygenase deficiency |
Tyrosinemia type III (disorder) |
| 4-quinolones overdose |
Quinolone antibacterial overdose |
| 4-quinolones overdose of undetermined intent |
Quinolone antibacterial overdose |
| 4-quinolones poisoning |
Fluoroquinolone poisoning (disorder) |
| 4-quinolones poisoning of undetermined intent |
Fluoroquinolone poisoning (disorder) |
| 5-OH indole acetic acid (& level (& urine)) (procedure) |
5-Hydroxyindoleacetic acid measurement, quantitative, urine |